EXHIBIT 10.34 RESEARCH SERVICES AGREEMENT ELI LILLY AND COMPANYResearch Services Agreement • November 16th, 2000 • Array Biopharma Inc • Services-medical laboratories • Indiana
RESEARCH SERVICES AGREEMENT CERTIFICATIONResearch Services Agreement • November 9th, 2021
PURPOSE: A Research Services Agreement (RSA) is to be used only on those Projects involving analysis and/or evaluation of Sponsor provided material or information. As no applied or basic research by the University is to be involved in these Projects and therefore it is not likely that there will be creation of new knowledge and/or technologies by University personnel, the provisions of the RSA grant any intellectual property within the scope of the Project to the Sponsor. As these provisions vary from the University’s Standard Research Agreement it is imperative that the RSA is used properly and not substituted for the University’s Standard Research Agreement. In an effort to avoid confusion and ensure proper use of the RSA, the following certification form needs to accompany any proposed Project involving a Research Services Agreement. A proposed Research Services Agreement will not be routed for approval or approved without execution of this Certification form.
RESEARCH SERVICES AGREEMENTResearch Services Agreement • August 5th, 2023
This Research Services Agreement (hereinafter “Agreement”), effective as of the date of last signature below (“Effective Date”), is made by and between _________________, having offices at ___________________(“SPONSOR”), and Emory University a non-profit corporation organized under the laws of the State of Georgia and having offices located at 1599 Clifton Rd NE, 4th Floor, Mailstop: 1599-001-1BA, Atlanta, GA 30322 (“Emory”).”Parties” means SPONSOR and Emory. “Party” means SPONSOR or Emory.
Research Services AgreementResearch Services Agreement • July 6th, 2021
RESEARCH SERVICES AGREEMENTResearch Services Agreement • March 8th, 2016 • Viking Therapeutics, Inc. • Pharmaceutical preparations • California
THIS RESEARCH SERVICES AGREEMENT (the “Agreement”) is made effective as of 27 January , 2015 (the “Effective Date”), by and between Viking Therapeutics, Inc., a Delaware corporation located at 11119 North Torrey Pines Road, Suite 50, La Jolla, CA 92037, USA (“Viking”) and Academisch Medisch Centrum, with registered office at Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands (“Institution”).
Research Services AgreementResearch Services Agreement • November 3rd, 2016 • Newlink Genetics Corp • Pharmaceutical preparations • Georgia
This Research Services Agreement (“Agreement”) is between Augusta University Research Institute, Inc. (“AURI”) a non-profit research and educational corporation, located at Augusta University (“University”), with principal offices at 1120 15th Street, Augusta, Georgia 30912-4810, and NewLink Genetics Corporation, with its principal offices at 2901 South Loop Drive, Ames, Iowa 50010 ("NewLink"). The parties may be referred to individually as “Party” and collectively as the “Parties.” David H. Munn, M.D., shall serve as principal investigator (“PI”) on behalf of AURI.
RESEARCH SERVICES AGREEMENTResearch Services Agreement • March 19th, 2014 • Scynexis Inc • Pharmaceutical preparations
This Research Services Agreement (this “Agreement”) is dated as of December 19, 2011 (the “Effective Date”), and is by and between MERIAL Limited, a company limited by shares registered in England and Wales (registered number 3332751) with a registered office at P.O. Box 327, Sandringham House, Sandringham Avenue, Harlow Business Park, Harlow, Essex CM19 5QA, England, and domesticated in Delaware, USA as MERIAL LLC, and having a place of business at 3239 Satellite Boulevard, Bldg. 500, Duluth, Georgia 30096 USA, on behalf of itself and any of its subsidiaries and/or Affiliates (hereinafter, “MERIAL”), and SCYNEXIS, Inc., a Delaware corporation having a place of business at 3501 C Tricenter Boulevard, Durham, NC 27713 (hereinafter, “SCYNEXIS”).
RESEARCH SERVICES AGREEMENTResearch Services Agreement • January 14th, 2019 • Dyadic International Inc • Industrial organic chemicals • Florida
This RESEARCH SERVICES AGREEMENT (this “Agreement”), signed as of June 30, 2017, is entered into by and between DYADIC INTERNATIONAL, INC., a Delaware corporation with headquarters located at 140 Intracoastal Pointe Drive, Suite 404, Jupiter, Florida 33477-5094 USA and U.S. tax identification number 45-04867472 (“Dyadic”), and BIOTECHNOLOGY DEVELOPMENTS FOR INDUSTRY IN PHARMACEUTICALS, S.L.U., a company incorporated under the laws of Spain having its registered office at Louist Proust 13, 47151 Boecillo (Valladolid), Spain, and identification code -CIF number- B-86206695 (“BDI Pharmaceuticals”). Dyadic and BDI Pharmaceuticals are sometimes collectively referred to as the “Parties” and individually as a “Party.” Certain capitalized terms used herein have the meanings assigned them in Article 1 hereof.
INSERT SPONSOR NAME]Research Services Agreement • June 15th, 2021
THIS AGREEMENT (“Agreement”) is made by and between the University of Vermont and State Agricultural College, a public land grant university of the state of Vermont, (hereafter referred to as "UVM"), whose address is Sponsored Project Administration, 217 Waterman Building, Burlington, VT 05405 and [INSERT NAME] (hereafter referred to as "SPONSOR"), whose address is [INSERT ADDRESS], each one a “Party” and collectively “Parties.”
RESEARCH SERVICES AGREEMENTResearch Services Agreement • January 5th, 2021 • New Jersey
THIS Agreement is made this _____ day of ________, 200_ ("Effective Date"), between the University of Medicine and Dentistry of New Jersey ("UMDNJ") with offices at 65 Bergen Street, Newark, New Jersey, 07107, and _______________________________ ("Subcontractor") with offices at _________________________, and to conduct research services ("Services"). Subcontractor and UMDNJ agree as follows:
RESEARCH SERVICES AGREEMENTResearch Services Agreement • September 24th, 2020 • Missouri
This Agreement is made and entered into, effective as of the last signature on this Agreement, (“Effective Date”) by and between: Washington University, a corporation established by special act of the Missouri General Assembly approved February 22, 1853 and acts amendatory thereto, having its principal offices at One Brookings Drive, St. Louis, Missouri 63130 (hereinafter referred to as "WU"); and _________________________ a corporation organized and existing under the laws of the State of ________________________, having its principal offices at _______________________________(hereinafter referred to as "Company").
Research Services Agreement AMENDMENT TO RESEARCH SERVICES AGREEMENTResearch Services Agreement • August 16th, 2013 • Ameritas Variable Separate Account Va-2 • Ohio
This amendment (“Amendment”), dated ______May 31____________, 2013 (“Effective Date”), is made to the Research Services Agreement, dated April 19, 2010 (“Agreement”), between Fund Evaluation Group, LLC (“FEG”), and Ameritas Life Insurance Corp. and The Union Central Life Insurance Company (referred to collectively herein as “Client”).
RESEARCH SERVICES AGREEMENTResearch Services Agreement • April 13th, 2012 • Orgenesis Inc. • Services-business services, nec
This Research Services Agreement (the "Agreement") is entered into as of this 22nd day of March, 2012 (the "Effective Date") by and between Tel Hashomer - Medical Research, Infrastructure and Services Ltd. ("THM") and Orgenesis Ltd. (the "Company").
RESEARCH SERVICES AGREEMENTResearch Services Agreement • April 5th, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations • New York
This Research Services Agreement (the “Agreement”) is made this 2nd day of February, 2016 (the “Signing Date”) by and between Ascentage Pharma Group Corp. Ltd., a [Hong Kong corporation] (“Ascentage”), with a business address at 11/F, AXA CENTRE, Gloucester Road, Wanchai, Hong Kong, and Unity Biotechnology, Inc., a Delaware corporation (“Unity”), with a business address at 1700 Owens Street, Suite 535, San Francisco, California 95158.
RESEARCH SERVICES AGREEMENTResearch Services Agreement • April 6th, 2016
Terms Sheet Parties University of Technology Sydney (ABN 77 257 686 961) of 15-73 Broadway, Ultimo, NSW, 2007 ("UTS")andEnter full legal name (ABN enter 11 digit ABN), of Enter prinicpal place of business (“You, Your") Project Name of Project and as further detailed in the Schedules. Term Start date: Enter a date.End date: Enter a date. or the date on which the final portion of the Fee is paid, whichever is the latter. Deliverables & Milestones As specified in the Schedule Fees(excl GST) $First instalment of feeon execution of this Agreement and$Second/final instalment fee on acceptance of the Final Report (subject to receipt of a valid tax invoice) UTS Lead/Faculty Name and Title Telephone Email address Addresses for Service: For UTSDirector, Research & Innovation OfficeUniversity of Technology Sydney PO Box 123,Broadway NSW 2007Tel: (02) 9514 9681Fax: (02) 9514 1244Email: rio@uts.edu.au For YouEnter Name and Title AddressTelephone Email Attachments ☐ General Terms and Conditions☐ Pro
RESEARCH SERVICES AGREEMENT M1701897Research Services Agreement • March 24th, 2017 • Texas
This Agreement constitutes a Research Services Agreement (“Agreement”) between Texas A&M Engineering Experiment Station (“TEES”), a member of The Texas A&M University System and an agency of the State of Texas, and the Galveston Island Park Board of Trustees (''Park Board").
Research Services Agreement (RSA)Research Services Agreement • March 20th, 2023
This agreement template is used in place of a standard FDP subcontract template when the University is purchasing research out of a fund 34 or 35. In rare cases, this can be used for funds 2X, 10, or 80. This is NOT appropriate for the purchase of consulting services out of a fund 30 or 31.
RESEARCH SERVICES AGREEMENTResearch Services Agreement • October 30th, 2012
Between: <If Company: [Company A],having its registered offices at [Insert registered offices]> <if Individual [Insert Full Name], residing at [Insert residential address]>, (“Contractor”);
ContractResearch Services Agreement • August 23rd, 2012 • Audeo Oncology, Inc. • Pharmaceutical preparations
[***] DENOTES CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT
INSERT SPONSOR NAME]Research Services Agreement • December 13th, 2018
THIS AGREEMENT (“Agreement”) is made by and between the University of Florida Board of Trustees, a public body public corporate of the state of Florida, (hereafter referred to as "UF"), whose address is UF Division of Sponsored Programs, 207 Grinter Hall, Box 115500, Gainesville, FL 32611-5500 and [INSERT NAME] (hereafter referred to as "SPONSOR"), whose address is [INSERT ADDRESS], each one a “Party” and collectively “Parties.”
Takashi Kiyoizumi, Ph.D., M.D. President and CEO MediciNova, Inc. Suite 400 San Diego, CA 92122 Re: Research Services Agreement Dear Dr. Kiyoizumi:Research Services Agreement • October 1st, 2004 • Medicinova Inc • Delaware
This is in reference to the Research Services Agreement between Medicinova and Tanabe Research Laboratories dated June 1, 2001 (“Agreement”).
TELMETRICS Inc. RESEARCH SERVICES AGREEMENT: Dex Media, Inc.Research Services Agreement • March 18th, 2019 • Marchex Inc • Services-business services, nec • Delaware
This Agreement (“Agreement”) is for services as described in Exhibit A, “Statement of Work”, attached hereto (the “Research Services”) and is made and entered into effective December 1, 2017 (the “Effective Date”) by and between TELMETRICS Inc., with its principal place of business located at 2680 Skymark Avenue, Suite 900, Mississauga, Ontario Canada L4W5L6 (“TELMETRICS”), and Dex Media, Inc. (“PUBLISHER”), a Delaware corporation, whose principal offices are located at 2200 West Airfield Drive, P.O. Box 619810, DFW Airport, Texas 75261, on behalf of itself and all of its subsidiaries.
RESEARCH SERVICES AGREEMENTResearch Services Agreement • March 30th, 2015 • Scynexis Inc • Pharmaceutical preparations
This Research Services Agreement (this “Agreement”) is dated as of December 24, 2014 (the “Effective Date”), and is by and between MERIAL INC., a Georgia company having a place of business at 3239 Satellite Boulevard, Bldg. 500, Duluth, Georgia 30096 USA, on behalf of itself and any of its subsidiaries and/or Affiliates (hereinafter, “MERIAL”), and SCYNEXIS, INC., a Delaware corporation having a place of business at 3501 C Tricenter Boulevard, Durham, NC 27713 (hereinafter, “SCYNEXIS”).
Research Services AgreementResearch Services Agreement • August 31st, 2016
The research Services Agreement is designed to ease faculty burden in setting up and proposing small, short term sponsored projects. The hope is that making it easier to conduct smaller projects will encourage more pilot studies and facilitate larger sponsored projects in the future.
RESEARCH SERVICES AGREEMENTResearch Services Agreement • December 28th, 2018 • Troms
As remuneration for the research services, the client shall pay the sum of NOK [NOK] plus MVA of NOK [NOK], totalling NOK [NOK] in accordance with the following payment plan:
This Contract Research Services AgreementResearch Services Agreement • March 14th, 2017
Affiliate shall mean, with respect to a Party to this Agreement, another legal entity Controlling, Controlled by or under ultimate common Control with such Party.
RESEARCH SERVICES AGREEMENT (UNIVERSITY PROVIDING SERVICES)Research Services Agreement • January 7th, 2014 • Nebraska
THIS RESEARCH SERVICES AGREEMENT (this “Agreement”), effective the day of , 20 , is entered into by and between the Board of Regents of the University of Nebraska, a public body corporate and governing body of the University of Nebraska-Lincoln
RESEARCH SERVICES AGREEMENTResearch Services Agreement • March 12th, 2021 • Victoria
Research Services Agreement between Cohen Independent Research Group And Pax Clean Energy PXCEResearch Services Agreement • March 30th, 2009 • Pax Clean Energy, Inc. • Industrial organic chemicals • California
This Agreement is entered into as of the date on the signature page hereof between Cohen Independent Research Group, (“CIRG”) and PAX CLEAN ENERGY PXCE for the provision of consulting services by Cohen Independent Research Group. In consideration for services rendered by CIRG to PAX CLEAN ENERGY PXCE parties agree to the following terms and conditions.
RESEARCH SERVICES AGREEMENTResearch Services Agreement • October 14th, 2021 • New York
This RESEARCH SERVICES AGREEMENT (“Agreement”) is made as of the «Day» day of «Month», «Year», by and between THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY FOR THE NEW YORK, a nonprofit, educational corporation existing under the laws of the State of New York, with an office located at Upstate Medical University, 705 E. Adam Street, Syracuse, NY, 13210] (the “Foundation”) on behalf of THE STATE UNIVERSITY OF NEW YORK– UPSTATE MEDICAL UNIVERSITY (“SUNY Upstate”) for its Proteomics & Mass Spectrometry Core Facility (both together “RF SUNY”), and «SPONSOR, a «Type» existing under the laws of the State of «SponState», with its principal offices located at «SponAdd», (the "Sponsor").
Research Services AgreementResearch Services Agreement • February 24th, 2024 • Australian Capital Territory
THE AUSTRALIAN NATIONAL UNIVERSITY (ABN 52 234 063 906) an educational and research institute and body corporate pursuant to the Australian National University Act 1991 (Cth) and represented by the College of Law, of Acton in the Australian Capital Territory, 2601 (University)
Research Services Agreement (RSA)Research Services Agreement • November 15th, 2021
This agreement template is used in place of a standard FDP subcontract template when the University is purchasing research services out of a fund 34 or 35 when there is no formal prime sponsor for the set-up of a fund 30 or 31. You can request an RSA using the formstack link below.
CLINICAL RESEARCH SERVICES AGREEMENTResearch Services Agreement • December 20th, 2007 • ChemoCentryx, Inc. • Pharmaceutical preparations
THIS CLINICAL RESEARCH SERVICES AGREEMENT (“Agreement”) made this 12th day of October 2006 (“Effective Date”), by and between CHEMOCENTRYX, INC., a Delaware corporation with its principal executive offices located at 850 Maude Avenue, Mountain View, CA 94043 (“Sponsor”), and KENDLE INTERNATIONAL INC., with its principal executive offices located at 441 Vine Street, 1200 Carew Tower, Cincinnati, OH 45202 (“Kendle”). Kendle and Sponsor may each be referred to individually as a “Party,” and collectively, as “Parties.”
RESEARCH SERVICES AGREEMENTResearch Services Agreement • May 16th, 2022 • Ampio Pharmaceuticals, Inc. • Pharmaceutical preparations • Colorado
This Research Services Agreement ("Agreement") is made on February 4, 2022 ("Effective Date"), and entered into by and between Ampio Pharmaceuticals, Inc., a Delaware corporation, having its address at 373 Inverness Parkway, Suite 200 Englewood, Colorado 80112 ("Company") and Trauma Research LLC, a Colorado limited liability company, having its address at 900 East Oxford Lane, Englewood, Colorado 80110 ("Contractor"). Company and Contractor may individually be referred to herein as "Party" and collectively as the "Parties".
RESEARCH SERVICES AGREEMENTResearch Services Agreement • August 3rd, 2007 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
This Research Services Agreement (“Agreement”) is entered into this 4th day of May, 2007, (the “Effective Date”) by and between Rosetta Genomics, Ltd., an Israeli corporation, having its principal place of business at 10 Plaut Street, Rehovot, Israel 76706 (“Rosetta”), and The Trustees of Columbia University in the City of New York, having a principal place of business at c/o Science & Technology Ventures, Columbia University, 630 West 168th Street, PH 1535 East, New York, New York 10032 (“University”). Rosetta and University may be referred to individually as a “Party” or collectively as “Parties.”
